Under construction – not a live service
Sign in
Taking peoplePhase 3

Efficacy of Auricular Pressure Beans with Electroacupuncture and Estazolam Treating Insomnia Caused by Cancer

Key facts

Phase
Phase 3

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Qinghai Red Cross Hospital
Trial code
NCT06859190
Record updated
25 March 2025
Original description
The core objectives of this study are to assess the short-term and long-term efficacy of auricular acupoint pressure beans combined with electroacupuncture and estazolam in the treatment of cancer-caused insomnia. The study aims to accurately compare the differences between this combination therapy and standard Western medicine in improving sleep quality and effectively alleviating anxiety and depression. Additionally, it will meticulously observe the safety of the combined treatment and record the occurrence and potential causative factors of any adverse reactions.Read full original descriptionShow less

Analysis of the Efficacy of Auricular Pressure Beans Combined with Electroacupuncture and Estazolam for the Treatment of Insomnia Induced by Cancer

The core objectives of this study are to assess the short-term and long-term efficacy of auricular acupoint pressure beans combined with electroacupuncture and estazolam in the treatment of cancer-caused insomnia. The study aims to accurately compare the differences between this combination therapy and standard Western medicine in improving sleep quality and effectively alleviating anxiety and depression. Additionally, it will meticulously observe the safety of the combined treatment and record the occurrence and potential causative factors of any adverse reactions.

Inclusion: Age 18 and above; The diagnosis of a malignant solid tumor was confirmed by pathological examination; Clinically diagnosed cancer-caused insomnia with insomnia symptoms lasting more than 1 month, more than 3 or more times per week; An Insomnia Severity Index (ISI) score of 8 or higher and meets the criteria for insomnia disorder as defined in the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition; No medications related to the treatment of insomnia have been used in the last 1 month; No serious dysfunction of the heart, liver, kidneys or other vital organs; Patients volunteered to participate in this study and signed an informed consent form.

Exclusion: Received acupuncture or auricular pressure bean therapy within the past 3 months; Inadequately treated for another sleep disorder (e.g., sleep disorder disorders such as sleep apnea obstruction syndrome, restless leg syndrome, etc.); Have a history of severe allergies, especially to the drugs or treatments used in this study; History of severe mental illness with a current episode; History of substance abuse or alcohol dependence; Irregular sleep-wake cycles in jobs with shift demands or due to inconsistent work schedules; Estimated life expectancy is ≥3 months.

ClinicalTrials.gov NCT06859190